Epidemiology of rubella in Finland

I Davidkin1, H Peltola, P Leinikki

  • 1National Public Health Institute (KTL), Helsinki, Finland.

Insights

Finland successfully eliminated rubella through its high-coverage measles, mumps, and rubella (MMR) vaccination program. This initiative has also eradicated congenital rubella syndrome, demonstrating vaccine effectiveness.

Area of Science:

  • Immunology
  • Epidemiology
  • Public Health

Background:

  • Rubella was historically endemic in Finnish children, causing periodic epidemics.
  • Rubella infection commonly occurred in children aged 2-12 years before vaccination.
  • Disease surveillance indicated epidemic cycles occurring every few years.

Purpose of the Study:

  • To evaluate the long-term impact of rubella vaccination programs in Finland.
  • To assess the effectiveness of the measles, mumps, and rubella (MMR) vaccination program in disease elimination.
  • To determine the cessation of indigenous rubella virus circulation and congenital rubella syndrome (CRS) incidence.

Main Methods:

  • Analysis of historical rubella incidence data before and after vaccination introduction.
  • Monitoring of vaccination coverage rates from the mid-1970s onwards.
  • Surveillance of imported rubella cases and secondary infections post-elimination.
  • Cohort studies to assess vaccine-induced antibody levels over time.

Main Results:

  • Rubella cases significantly reduced following the MMR vaccination program launch in 1982.
  • Indigenous rubella virus circulation ceased in Finland by the late 1990s due to sustained high vaccination coverage (>95%).
  • Congenital rubella syndrome (CRS) was eliminated, with the last case in 1986.
  • Imported rubella cases did not result in secondary transmission, indicating effective population immunity.
  • Cohort studies suggest a gradual decrease in vaccine-induced antibody levels over time.

Conclusions:

  • The high-coverage, two-dose MMR vaccination program successfully eliminated rubella and congenital rubella syndrome in Finland.
  • Sustained population immunity effectively prevents sustained transmission of indigenous rubella virus.
  • Ongoing monitoring is necessary to ascertain the duration of vaccine-induced protection.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...